Not applicableUnknownNCT00402090What this trial is testingDHPLC Determination of TPMT Polymorphisms.Who this might be right forAcute Lymphoblastic Leukemia National Institute of Cancerología 160
Testing effectiveness (Phase 2)Study completedNCT00548847What this trial is testingImmunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic TransplantationWho this might be right forLeukemia Emory University 15
Testing effectiveness (Phase 2)Ended earlyNCT05086315What this trial is testingFirst-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Who this might be right forAcute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more Sanofi 101
Testing effectiveness (Phase 2)Study completedNCT00702403What this trial is testingNilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CMLWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more Fred Hutchinson Cancer Center 40
Post-approval studies (Phase 4)Study completedNCT00526305What this trial is testingLAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia PositiveWho this might be right forAcute Lymphoblastic Leukemia PETHEMA Foundation 100
Early research (Phase 1)Study completedNCT01756118What this trial is testingA Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Myelocytic, AcuteChronic Myelogenous Leukemia With Crisis of Blast Cells Goethe University 24
Not applicableStudy completedNCT04456959What this trial is testingInO - A Retrospective Study of UK Patients With LeukaemiaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Pfizer 28
Not applicableStudy completedNCT01626183What this trial is testingStudying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 20
Early research (Phase 1)Study completedNCT00098423What this trial is testingTanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT05959720What this trial is testingAdult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilWho this might be right forAcute Lymphoid LeukemiaMinimal Residual DiseaseGene Abnormality+1 more Instituto do Cancer do Estado de São Paulo 180
Large-scale testing (Phase 3)Study completedNCT03476239What this trial is testingEfficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen 121
Early research (Phase 1)Not Yet RecruitingNCT07623681What this trial is testingSingle-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/LymphomaWho this might be right forCD7+ T-ALL/LBL PersonGen BioTherapeutics (Suzhou) Co., Ltd. 12
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Large-scale testing (Phase 3)Study completedNCT00005945What this trial is testingComparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 3,054
Not applicableStudy completedNCT03463694What this trial is testingEdinburgh and Lothian Virus Intervention Study in KidsWho this might be right forUpper Respiratory Tract InfectionsVirusVirus Shedding+1 more University of Edinburgh 407
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144
Early research (Phase 1)Study completedNCT00025129What this trial is testingVNP40101M in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Vion Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01520922What this trial is testingOfatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Leukaemia, Lymphocytic, Chronic Novartis Pharmaceuticals 99
Testing effectiveness (Phase 2)Study completedNCT00005802What this trial is testingChemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center